Elevation Wealth Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VF
AT
AS
TIM
CISOA
DJSG
MIF
Elevation Wealth Partners's RMD Position: Q2 2026 in Review
Elevation Wealth Partners increased its ResMed (RMD) stake by 78% in Q2 2026, buying an estimated $1.45K and bringing the position to 16 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1118.
Elevation Wealth Partners first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $4.38K in Q3 2025. 265 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Elevation Wealth Partners held 16 shares of ResMed worth $3.12K as of Q2 2026.
- Elevation Wealth Partners bought 7 ResMed shares in Q2 2026, an estimated $1.45K.
- ResMed made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #1118 holding.
- Elevation Wealth Partners first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
- Elevation Wealth Partners's ResMed position peaked at $4.38K in Q3 2025.
- 265 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.